Opioid Abuse Deterrence: Purdue Expects Quick Results On OxyContin, But Cmte. Wonders About Duration Of Effect

The surveillance system for tracking adverse events associated with the reformulated drug continues to evolve, the firm tells an FDA advisory panel.